Jinwon Life Sciences Signs Supply Contract Worth 2.5 Billion KRW
[Asia Economy Reporter Eunmo Koo] Jinwon Life Sciences announced on the 1st that it has signed a Plasmid DNA supply contract worth 2.4528 billion KRW with a bio company in the United States. The contract amount represents 5.95% of last year's consolidated sales, and the contract period is until March 31 of next year.
Hot Picks Today
!["It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]](https://cwcontent.asiae.co.kr/asiaresize/93/2026052019230771274_1779272587.jpg)
"It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- [Breaking] Samsung Electronics Labor and Management Officially Sign Tentative Agreement
- [Report] "I Think Twice Before Going to a Store"... Starbucks '5/18 Tank Day' Controversy Grows
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![[Breaking] Samsung Electronics Labor and Management Officially Sign Tentative Agreement](https://cwcontent.asiae.co.kr/asiaresize/307/2026052022492353201A.jpg)
